Clinical profile and treatment outcome of Tuberculous Lymphadenitis in children using DOTS strategy.
Artículo
en Inglés
| IMSEAR
| ID: sea-146829
ABSTRACT
Background:
Extra pulmonary TB (EPTB) including tuberculous lymphadenitis is becoming more common probably due to human immuno deficiency virus (HIV) co-infection. While children do experience a high TB related morbidity and mortality, management of TB in children is challenging. The present study was designed to study the treatment outcome of DOTS strategy for pediatric tuberculous lymphadenitis.Objective:
To study the efficacy of DOTS strategy for pediatric lymphhnode tuberculosis.Methods:
Retrospective analysis of 669 children of lymphnode tuberculosis treated with DOTS strategy over 9½ years.Results:
Mean age was 9.8 years with significantly more girls (61.3%) than boys (38.7%) {c2=34.08, P< 0.001 (S)}. Most of the patients were in the age group of 11-14 years (48.0%) followed by 6-10 years(34.5%) and 0-5 years(17.5%) respectively. Cervical tuberculous lymphadenitis (88.2%) was the commonest form for all ages followed by axillary lymphadenitis in 3.3%. TB of other sites was seen in only 57 (8.5%) cases. Out of total 622 (93%) cases of lymphnode TB where fine needle aspiration and/ or excisional biopsy was done, it was positive (84.2%) and negative (15.6%) respectively for AFB/ cytology, while it could not be done in 47 patients due to inaccessible sites. Category I, II and III was started on 15.4%, 7.5% and 77.1% patients respectively. Overall, treatment completion rate was 94.9% and the default rate was 2.2% with a failure rate of 2.5%. Death rate was 0.3%.Conclusion:
The study confirms the efficacy of DOTS strategy for pediatric TB lymphadenitis
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Idioma:
Inglés
Año:
2010
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS